MARCHESE, PAOLA VALERIA
 Distribuzione geografica
Continente #
NA - Nord America 135
AS - Asia 101
EU - Europa 87
AF - Africa 15
OC - Oceania 3
Totale 341
Nazione #
US - Stati Uniti d'America 135
SG - Singapore 56
IT - Italia 39
CN - Cina 23
IE - Irlanda 10
IN - India 10
SE - Svezia 9
CI - Costa d'Avorio 7
DE - Germania 6
FI - Finlandia 6
JO - Giordania 6
CH - Svizzera 5
TG - Togo 5
BG - Bulgaria 4
ID - Indonesia 4
AU - Australia 3
GB - Regno Unito 3
NG - Nigeria 2
NL - Olanda 2
AT - Austria 1
BD - Bangladesh 1
BE - Belgio 1
RU - Federazione Russa 1
SN - Senegal 1
VN - Vietnam 1
Totale 341
Città #
Singapore 52
Santa Clara 25
Ashburn 17
Chandler 13
Boardman 10
Dublin 10
Hyderabad 9
Abidjan 7
Bologna 7
Amman 6
Helsinki 5
Lomé 5
Bern 4
Jakarta 4
New York 4
Princeton 4
Rimini 4
Sofia 4
Beijing 3
Modena 3
Abeokuta 2
Bari 2
Berlin 2
Borgomanero 2
Bremen 2
Enschede 2
Ferrara 2
Melbourne 2
Milan 2
Palermo 2
Seattle 2
Southend 2
Turin 2
Verona 2
Woodbridge 2
Boydton 1
Brussels 1
Canberra 1
Chicago 1
Fairfield 1
Florence 1
Forlì 1
Hanoi 1
Harbin 1
Jinan 1
Lappeenranta 1
Los Angeles 1
Lugano 1
Mülheim 1
Nanjing 1
Nanyang 1
Olalla 1
Phoenix 1
Prescot 1
Qingdao 1
Rajshahi 1
Shenzhen 1
Trento 1
Vienna 1
Wuhan 1
Totale 251
Nome #
Baseline total metabolic tumour volume on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography-computed tomography as a promising biomarker in patients with advanced non-small cell lung cancer treated with first-line pembrolizumab. 61
Large Cell Neuroendocrine Carcinoma of the Lung: Current Understanding and Challenges 60
Monitoring tumor growth rate to predict immune checkpoint inhibitors' treatment outcome in advanced NSCLC 52
A hypothesis-generating analysis on the role of TERT promoter mutation in advanced urothelial carcinoma treated with immunotherapy 38
Lymph node ratio predicts efficacy of postoperative radiation therapy in nonmetastatic Merkel cell carcinoma: A population-based analysis 36
Implications of TERT promoter mutations and telomerase activity in solid tumors with a focus on genitourinary cancers 30
Agnostic Approvals in Oncology: Getting the Right Drug to the Right Patient with the Right Genomics 29
TERT promoter mutations and the outcome of patients with advanced urothelial carcinoma treated by platinum-based chemotherapy or pembrolizumab 22
Clinical Utility and Application of Liquid Biopsy Genotyping in Lung Cancer: A Comprehensive Review 19
Development and validation of a new tool to estimate early mortality in patients with advanced cancer treated with immunotherapy 14
Totale 361
Categoria #
all - tutte 1.772
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.772


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202220 0 0 0 0 0 0 0 7 0 0 6 7
2022/2023130 7 11 2 4 16 9 7 10 32 4 12 16
2023/202456 6 8 3 4 2 20 0 3 1 2 7 0
2024/2025155 29 37 15 26 40 8 0 0 0 0 0 0
Totale 361